| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2011 | CA2441260C Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
| 04/26/2011 | CA2433186C Delayed release pharmaceutical formulations |
| 04/26/2011 | CA2432438C Flexible microchip devices for ophthalmic and other applications |
| 04/26/2011 | CA2428785C Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 04/26/2011 | CA2424565C Novel crystalline forms of a factor xa inhibitor |
| 04/26/2011 | CA2420410C Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 04/26/2011 | CA2388656C Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 04/26/2011 | CA2386023C Mucosal dtpa vaccines |
| 04/26/2011 | CA2377529C Injectable hyaluronate-sulfated polysaccharide conjugates |
| 04/26/2011 | CA2371109C Improved pharmaceutical formulations |
| 04/26/2011 | CA2359945C Inhibitors of crystallization in a solid dispersion |
| 04/26/2011 | CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 04/26/2011 | CA2341358C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 04/26/2011 | CA2306024C Buccal, polar and non-polar spray or capsule |
| 04/21/2011 | WO2011047277A2 Release of agents from cells |
| 04/21/2011 | WO2011047227A2 Water soluble drug-solubilizer powders and their uses |
| 04/21/2011 | WO2011047143A1 Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting |
| 04/21/2011 | WO2011047047A2 Composites containing polypeptides attached to polysaccharides and molecules |
| 04/21/2011 | WO2011046832A2 Granulysin in immunotherapy |
| 04/21/2011 | WO2011046733A1 Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| 04/21/2011 | WO2011046627A1 Water soluble colonoscopy lubricant |
| 04/21/2011 | WO2011046609A2 Encapsulation |
| 04/21/2011 | WO2011046546A1 Delayed release compositions |
| 04/21/2011 | WO2011046443A1 Ultrasound triggered controlled release drug delivery |
| 04/21/2011 | WO2011046199A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same |
| 04/21/2011 | WO2011046024A1 Adhesive patch |
| 04/21/2011 | WO2011046023A1 Method and device for producing adhesive patch |
| 04/21/2011 | WO2011045934A1 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same |
| 04/21/2011 | WO2011045809A1 Liposomal amphotericin formulation comprising cholesterol for treating fungal infections |
| 04/21/2011 | WO2011045803A1 Sore relief formulation |
| 04/21/2011 | WO2011045775A1 A delayed release pharmaceutical composition of mesalamine |
| 04/21/2011 | WO2011045774A2 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof |
| 04/21/2011 | WO2011045769A2 Anti-misuse solid oral dosage form provided having a modified specific release profile |
| 04/21/2011 | WO2011045764A1 A product for delivering antimicrobially active substances to an infected site |
| 04/21/2011 | WO2011045760A2 Micronized olmesartan medoxomil compositions |
| 04/21/2011 | WO2011045747A1 Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy |
| 04/21/2011 | WO2011045682A2 Active agent containing polymer network delivery composition and articles using the same |
| 04/21/2011 | WO2011045681A2 Carbohydrate entrapped active agent delivery composition and articles using the same |
| 04/21/2011 | WO2011045550A1 Method for preparing a recyclable polyamide powder |
| 04/21/2011 | WO2011045432A1 Improved medicinal aerosol formulations |
| 04/21/2011 | WO2011045429A1 Improved formulations |
| 04/21/2011 | WO2011044742A1 Medicaments for inhibiting thrombosis |
| 04/21/2011 | WO2011044736A1 Pharmaceutical composition for treating skin injury, preparation method of its ointment and use thereof |
| 04/21/2011 | WO2011044671A1 Porphyrin nanovesicles |
| 04/21/2011 | WO2011018246A3 Controlled release paliperidone composition |
| 04/21/2011 | WO2011017297A3 Liposomes comprising a calcium phosphate - containing precipitate |
| 04/21/2011 | WO2011004175A3 Viscous topical antimicrobial compositions |
| 04/21/2011 | WO2010150984A3 Amorphous adefovir dipivoxil solid dispersion with improved stability, and method for preparing same |
| 04/21/2011 | WO2010149727A3 Injectable formulations containing asenapine and method of treatment using same |
| 04/21/2011 | WO2010144755A3 Compositions and methods for delivery of materials |
| 04/21/2011 | WO2010141956A3 Methods and compositions for the treatment of cancer |
| 04/21/2011 | WO2010138884A3 Respiratory delivery of active agents |
| 04/21/2011 | WO2010138519A9 Use of adsorbent carbon microspheres for the treatment of pruritus |
| 04/21/2011 | WO2010138469A3 Two-piece bandage system, swab and cotton product |
| 04/21/2011 | WO2010137888A3 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same |
| 04/21/2011 | WO2010136588A3 Dry powder fibrin sealant |
| 04/21/2011 | WO2010132474A3 Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields |
| 04/21/2011 | WO2010132471A3 Synthesis of stable elastomeric negative acoustic contrast particles |
| 04/21/2011 | WO2010129819A3 Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| 04/21/2011 | WO2010123945A3 Silk fibroin hydrogels and uses thereof |
| 04/21/2011 | WO2010120817A3 Nanochanneled device and related methods |
| 04/21/2011 | WO2010115728A9 A method for avoiding glass fogging |
| 04/21/2011 | WO2010114629A9 Formulation |
| 04/21/2011 | WO2010105822A3 Dry processing of retigabine |
| 04/21/2011 | WO2010102071A8 Sustained release oral dosage forms of an r-baclofen prodrug |
| 04/21/2011 | WO2010067199A3 Mixtures of plants in spagyric mother tincture for dry cough in babies |
| 04/21/2011 | WO2010031532A3 Granulate in particular as a pharmaceutical vehicle for lipophilic medicaments |
| 04/21/2011 | WO2008114149A3 Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains |
| 04/21/2011 | US20110093020 Poly-porous hollow screw for target delivery of growth factors and stem cells:the design and potential clinical application |
| 04/21/2011 | US20110092961 Artificial cells |
| 04/21/2011 | US20110092953 Flowable Carrier Matrix |
| 04/21/2011 | US20110092926 Abuse potential reduction in abusable substance dosage form |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092603 Composition to enhance the bioavailability of curcumin |
| 04/21/2011 | US20110092471 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 04/21/2011 | US20110091570 Compositions and Devices for Antisepsis and Anticoagulation |
| 04/21/2011 | US20110091566 Controlled release pharmaceutical compositions |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091564 Injectable hollow tissue filler |
| 04/21/2011 | US20110091563 Orally-disintergrating solid preparation |
| 04/21/2011 | US20110091562 Nanogels for cellular delivery of therapeutics |
| 04/21/2011 | US20110091561 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 04/21/2011 | US20110091560 Compositions of nanoparticles and methods of making the same |
| 04/21/2011 | US20110091559 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| 04/21/2011 | US20110091558 Pharmaceutical Compositions of Entacapone, Levodopa and Carbidopa with Improved Bioavailability |
| 04/21/2011 | US20110091557 Composite material |
| 04/21/2011 | US20110091556 Antimicrobial compositions and methods of use |
| 04/21/2011 | US20110091555 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders. |
| 04/21/2011 | US20110091554 Injectable composite material suitable for use as a bone substitute |
| 04/21/2011 | US20110091553 Method for producing microcapsules using solid fat |
| 04/21/2011 | US20110091552 Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions |
| 04/21/2011 | US20110091551 Wound covering comprising octenidine dihydrochloride for use in the antisepsis of catheter insertion points |
| 04/21/2011 | US20110091550 Methods for Promoting the Revascularization and Reenervation of CNS Lesions |
| 04/21/2011 | US20110091549 Modulating Drug Release Rate By Controlling The Kinetics Of The pH Transition In Hydrogels |
| 04/21/2011 | US20110091548 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 04/21/2011 | US20110091547 Pharmaceutical Compositions Comprising Brivaracetam |
| 04/21/2011 | US20110091546 Composition for rapid disintegrating tablet in oral cavity |
| 04/21/2011 | US20110091545 Direct Injection moldable and rapidly disintegrating tablet matrix |
| 04/21/2011 | US20110091544 Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |